MNACVPR
Activase (alteplase), a genetically engineered version of tissue plasminogen activator (t-PA), is the only drug approved by the Food and Drug Administration for treating the sudden onset of ischemic stroke. The drug dissolves blood clots that block blood flow to the brain, improving the chance for recovery and decreasing disability. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.